CL2008001817A1 - Sales piperazina, benzatina y colina en forma cristalina del acido {4,6-bis(dimetilamino-2-)4-(4-(trifluorometil)benzamido)bencil)pirimidin-5-il)acético; proceso de preparación; composición farmacéutica; y uso en el tratamiento de enfermedades inflamatorias tales como asma, rinitis alérgica, crohn, entre otras. - Google Patents
Sales piperazina, benzatina y colina en forma cristalina del acido {4,6-bis(dimetilamino-2-)4-(4-(trifluorometil)benzamido)bencil)pirimidin-5-il)acético; proceso de preparación; composición farmacéutica; y uso en el tratamiento de enfermedades inflamatorias tales como asma, rinitis alérgica, crohn, entre otras.Info
- Publication number
- CL2008001817A1 CL2008001817A1 CL2008001817A CL2008001817A CL2008001817A1 CL 2008001817 A1 CL2008001817 A1 CL 2008001817A1 CL 2008001817 A CL2008001817 A CL 2008001817A CL 2008001817 A CL2008001817 A CL 2008001817A CL 2008001817 A1 CL2008001817 A1 CL 2008001817A1
- Authority
- CL
- Chile
- Prior art keywords
- benzamido
- pyrimidin
- crohn
- asthma
- dimethylamino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Abstract
Sal en forma cristalina que comprende una amina y el ácido {4,6-bis(dimetilamino-2-)4-(4-(trifluorometil)benzamido)bencil)pirimidin-5-il}acético; proceso de preparación; composición farmacéutica; y uso en el tratamiento de enfermedades inflamatorias, tales como, asma, rinitis alérgica, Crohn, entre otras.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US93673607P | 2007-06-21 | 2007-06-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2008001817A1 true CL2008001817A1 (es) | 2009-03-13 |
Family
ID=39731477
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2008001817A CL2008001817A1 (es) | 2007-06-21 | 2008-06-19 | Sales piperazina, benzatina y colina en forma cristalina del acido {4,6-bis(dimetilamino-2-)4-(4-(trifluorometil)benzamido)bencil)pirimidin-5-il)acético; proceso de preparación; composición farmacéutica; y uso en el tratamiento de enfermedades inflamatorias tales como asma, rinitis alérgica, crohn, entre otras. |
Country Status (23)
Country | Link |
---|---|
US (1) | US8278310B2 (es) |
EP (1) | EP2176240A1 (es) |
JP (1) | JP6006914B2 (es) |
KR (1) | KR20100039350A (es) |
CN (4) | CN102875478A (es) |
AR (1) | AR067118A1 (es) |
BR (1) | BRPI0812597A2 (es) |
CA (1) | CA2690436A1 (es) |
CL (1) | CL2008001817A1 (es) |
CO (1) | CO6251286A2 (es) |
EC (1) | ECSP109851A (es) |
HK (1) | HK1144940A1 (es) |
IL (1) | IL202755A0 (es) |
MA (1) | MA31536B1 (es) |
MX (1) | MX2009013813A (es) |
MY (1) | MY149005A (es) |
NZ (1) | NZ581856A (es) |
RU (1) | RU2468013C2 (es) |
TN (1) | TN2009000517A1 (es) |
TW (1) | TWI419693B (es) |
UA (1) | UA101326C2 (es) |
WO (1) | WO2008156781A1 (es) |
ZA (1) | ZA200909110B (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1471057T3 (da) | 2003-04-25 | 2006-05-15 | Actimis Pharmaceuticals Inc | Pyrimidinyleddikesyrederivater, der er egnede til behandlingen af sygdomme medieret af CRTH2 |
CA2735722A1 (en) * | 2008-09-02 | 2010-03-11 | Actimis Pharmaceuticals, Inc. | Isotopically enriched pyrimidin-5-yl acetic acid derivatives as crth2 antagonists |
US20120129820A1 (en) * | 2009-02-09 | 2012-05-24 | Boehringer Ingelheim International Gmbh | New pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders |
EP2451787B1 (en) | 2009-07-06 | 2013-04-24 | Boehringer Ingelheim International GmbH | Polymorph of [4,6-bis(dimethylamino)-2-(4-{[4-(trifluoromethyl)benzoyl]amino}benzyl)pyrimidin-5-yl] |
US20120302584A1 (en) | 2009-11-24 | 2012-11-29 | Boehringer Ingelheim International Gmbh | Novel salts forms of pyrimidin-5-yl acetic acid derivative |
EP2504319A1 (en) * | 2009-11-24 | 2012-10-03 | Boehringer Ingelheim International GmbH | Process for preparing a polymorph of the choline salt of a pyrimidin-5-yl acetic acid derivative |
EP2598145A1 (en) | 2010-07-28 | 2013-06-05 | Boehringer Ingelheim International GmbH | Pharmaceutical composition for treatment of respiratory and inflammatory diseases |
EP2598143A1 (en) * | 2010-07-28 | 2013-06-05 | Boehringer Ingelheim International GmbH | Pharmaceutical compositions for treatment of respiratory and inflammatory diseases |
EP2457900A1 (en) | 2010-11-25 | 2012-05-30 | Almirall, S.A. | New pyrazole derivatives having CRTh2 antagonistic behaviour |
US20140328861A1 (en) | 2011-12-16 | 2014-11-06 | Atopix Therapeutics Limited | Combination of CRTH2 Antagonist and a Proton Pump Inhibitor for the Treatment of Eosinophilic Esophagitis |
EP3108460A1 (en) | 2014-02-18 | 2016-12-28 | Bekey A/S | Controlling access to a location |
RU2019128534A (ru) | 2017-02-15 | 2021-03-16 | Наньян Текнолоджикал Юниверсити | Химические соединения для лечения туберкулеза |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA005245B1 (ru) * | 2000-04-26 | 2004-12-30 | Уорнер-Ламберт Компани | Комбинация карбоксиалкиловых эфиров и гипотензивных агентов и фармацевтическое применение |
US7078690B2 (en) * | 2002-02-04 | 2006-07-18 | Applied Materials, Israel, Ltd. | Monitoring of contact hole production |
DK1471057T3 (da) | 2003-04-25 | 2006-05-15 | Actimis Pharmaceuticals Inc | Pyrimidinyleddikesyrederivater, der er egnede til behandlingen af sygdomme medieret af CRTH2 |
SE0301569D0 (sv) * | 2003-05-27 | 2003-05-27 | Astrazeneca Ab | Novel compounds |
BRPI0609739A2 (pt) * | 2005-04-07 | 2011-10-18 | Teijin Pharma Ltd | cristal, forma amorfa, método para produzir o cristal, composição farmacêutica, composição antagonista de receptor de quimiocina, e, droga preventiva ou droga terapêutica para doença |
UA99138C2 (ru) * | 2007-06-21 | 2012-07-25 | Актимис Фармасьютикалз, Инк. | Частичка антагониста crth2 (варианты) |
CA2735722A1 (en) * | 2008-09-02 | 2010-03-11 | Actimis Pharmaceuticals, Inc. | Isotopically enriched pyrimidin-5-yl acetic acid derivatives as crth2 antagonists |
-
2008
- 2008-06-18 WO PCT/US2008/007590 patent/WO2008156781A1/en active Application Filing
- 2008-06-18 CN CN2012103215909A patent/CN102875478A/zh active Pending
- 2008-06-18 MY MYPI20095423A patent/MY149005A/en unknown
- 2008-06-18 JP JP2010513235A patent/JP6006914B2/ja not_active Expired - Fee Related
- 2008-06-18 KR KR1020107001490A patent/KR20100039350A/ko not_active Application Discontinuation
- 2008-06-18 US US12/665,705 patent/US8278310B2/en not_active Expired - Fee Related
- 2008-06-18 CA CA2690436A patent/CA2690436A1/en not_active Abandoned
- 2008-06-18 UA UAA201000543A patent/UA101326C2/ru unknown
- 2008-06-18 CN CN2012103209664A patent/CN102898380A/zh active Pending
- 2008-06-18 BR BRPI0812597-0A2A patent/BRPI0812597A2/pt not_active IP Right Cessation
- 2008-06-18 RU RU2010101795/04A patent/RU2468013C2/ru not_active IP Right Cessation
- 2008-06-18 CN CN2012103213763A patent/CN102898381A/zh active Pending
- 2008-06-18 EP EP08768583A patent/EP2176240A1/en not_active Withdrawn
- 2008-06-18 NZ NZ581856A patent/NZ581856A/en not_active IP Right Cessation
- 2008-06-18 MX MX2009013813A patent/MX2009013813A/es active IP Right Grant
- 2008-06-18 CN CN2008801019629A patent/CN101772489B/zh not_active Expired - Fee Related
- 2008-06-19 CL CL2008001817A patent/CL2008001817A1/es unknown
- 2008-06-20 AR ARP080102675A patent/AR067118A1/es not_active Application Discontinuation
- 2008-06-20 TW TW097123238A patent/TWI419693B/zh not_active IP Right Cessation
-
2009
- 2009-12-10 TN TNP2009000517A patent/TN2009000517A1/fr unknown
- 2009-12-15 IL IL202755A patent/IL202755A0/en unknown
- 2009-12-21 ZA ZA2009/09110A patent/ZA200909110B/en unknown
- 2009-12-30 CO CO09149186A patent/CO6251286A2/es not_active Application Discontinuation
-
2010
- 2010-01-06 EC EC2010009851A patent/ECSP109851A/es unknown
- 2010-01-19 MA MA32540A patent/MA31536B1/fr unknown
- 2010-12-13 HK HK10111559.8A patent/HK1144940A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MY149005A (en) | 2013-06-28 |
CN101772489B (zh) | 2013-02-20 |
RU2468013C2 (ru) | 2012-11-27 |
CN101772489A (zh) | 2010-07-07 |
US20110034482A1 (en) | 2011-02-10 |
JP2010530426A (ja) | 2010-09-09 |
RU2010101795A (ru) | 2011-07-27 |
HK1144940A1 (en) | 2011-03-18 |
CN102898381A (zh) | 2013-01-30 |
TN2009000517A1 (en) | 2011-03-31 |
CO6251286A2 (es) | 2011-02-21 |
JP6006914B2 (ja) | 2016-10-12 |
MX2009013813A (es) | 2010-02-03 |
NZ581856A (en) | 2011-05-27 |
UA101326C2 (en) | 2013-03-25 |
CN102898380A (zh) | 2013-01-30 |
US8278310B2 (en) | 2012-10-02 |
WO2008156781A1 (en) | 2008-12-24 |
CN102875478A (zh) | 2013-01-16 |
TWI419693B (zh) | 2013-12-21 |
MA31536B1 (fr) | 2010-07-01 |
ECSP109851A (es) | 2010-03-31 |
KR20100039350A (ko) | 2010-04-15 |
EP2176240A1 (en) | 2010-04-21 |
ZA200909110B (en) | 2011-03-30 |
AR067118A1 (es) | 2009-09-30 |
TW200911261A (en) | 2009-03-16 |
BRPI0812597A2 (pt) | 2015-02-18 |
IL202755A0 (en) | 2010-06-30 |
AU2008266854A1 (en) | 2008-12-24 |
CA2690436A1 (en) | 2008-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2008001817A1 (es) | Sales piperazina, benzatina y colina en forma cristalina del acido {4,6-bis(dimetilamino-2-)4-(4-(trifluorometil)benzamido)bencil)pirimidin-5-il)acético; proceso de preparación; composición farmacéutica; y uso en el tratamiento de enfermedades inflamatorias tales como asma, rinitis alérgica, crohn, entre otras. | |
CL2008001818A1 (es) | Ácido {4,6-bis(dimetilamino)-2-(4-(4-(trifluorometil)benzamido)bencil)pirimidin-5-il}acético amorfo y sus formas cristalinas i y ii; proceso de preparación; composición farmacéutica; y uso en el tratamiento de enfermedades inflamatorias tales como asma, rinitis alérgica, crohn, entre otras. | |
CL2017003445A1 (es) | Formas solidas y formulaciones de compuestos de imidazopirazina. | |
UY36943A (es) | PIRAZOLO[3,4-b]PIRIDIN-6-CARBOXAMIDAS N-SULFONILADAS Y MÉTODO PARA SU USO | |
ECSP14013173A (es) | 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil) carbamimidoil)pirazina-2-carboxamida | |
CO7170178A2 (es) | Lh-pirazolo[3,4-b]piridinas y usos terapéuticos de las mismas | |
CO7131357A2 (es) | Compuestos de n-ariltriazol como antagonistas de lpar | |
CR9832A (es) | Compuestos de pirimidina amida como inhibidores de pgds | |
CO7131358A2 (es) | Compuestos de n-alquiltriazol como antagonistas de lpar | |
BR112015017997A2 (pt) | amidas de quinolina e quinazolina como moduladores de canais de sódio | |
GEP201706780B (en) | Substituted 2-aza-bicyclo [2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c | |
ECSP14006132A (es) | Derivados de ácido benzotiazol-6-il acético y su uso para tratar una infección por vih | |
CO6460766A2 (es) | Compuestos de haloalquil heteroaril benzamida | |
WO2014028589A3 (en) | 4-HETEROARYL SUBSTITUTED BENZOIC ACID COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF | |
CL2008003096A1 (es) | Compuestos derivados de piperidino-dihidrotienopirimidinas; inhibidores pde4; composicion farmaceutica que los comprende; y uso en el tratamiento de trastornos o enfermedades de las vias respiratorias o gastrointestinales, como tambien enfermedades inflamatorias de las articulaciones u ojos, entre otras. | |
CO6321253A2 (es) | Formas cristalinas y dos formas solvatadas de sales de acido lactico de la 4- amino-5- fluoro-3-[5-(4-metil-piperazin-1-il)1h-bencimidazol-2-il]-quinolin-2(1h)-ona | |
NI201100205A (es) | Sales de disacarina, ácido difumárico, acido di - 1 - hidroxi - 2 - naftoico y ácido monobenzoico del 2 - ( 4 - (( 2 - amino - 4 - metil - 6 - ( pentilamino ) pirimidin - 5 - il ) metil ) fenil ) acetato de 4 - ( dimetilamino ) butilo | |
ES2570332T3 (es) | La combinación de anticolinérgicos y antagonistas del receptor de leucotrieno para el tratamiento de enfermedades respiratorias | |
BR112016011170A8 (pt) | derivados de heteroaril ácido butanoico, seus usos, combinação e composição farmacêutica | |
BR112015004529A8 (pt) | alcóxi pirazóis, seu uso como ativadores de guanilato ciclase solúvel e composição farmacêutica que os compreende | |
CL2008003181A1 (es) | Sal del acido 3-[5-(piridin-2-il-metoxi)-3-(2-metil-2-propiltio)-1-[4-(2-metoxipiridin-5-il)bencil]-indol-2-il]-2,2-dimetil-propionico; fromas crsitalinas de la sal sodica; proceso de preparacion; composiciones farmaceuticas; kit farmaceutico, y uso para el tratamiento de asma. | |
CL2012001836A1 (es) | Compuestos de pirazol, antagonista de crth2; composicion farmacéutica; uso en el tratamiento de trastornos inflamatorios, infecciosos, inmunoreguladores, enfermedades respiratorias, gastrointestinales o dolencias, entre otros. | |
CO6491060A2 (es) | Compuestos y composiciones para el tratamiento de enfermedades parasitarias | |
CR10356A (es) | Derivados de 4-benzilphthalazinona 2-sustituidos como antagonistas de histamina h1 y h3 | |
BR112015006524A2 (pt) | derivados de quinazolinona como inibidores de parp |